CN Stock MarketDetailed Quotes

002793 Luoxin Pharmaceuticals Group Stock

Watchlist
  • 4.25
  • +0.05+1.19%
Market Closed Dec 20 15:00 CST
4.62BMarket Cap-6.63P/E (TTM)

Luoxin Pharmaceuticals Group Stock Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Product Currency:CNY
2024/H1
Stock NameRevenueRatio
Antibiotics504.69M40.08%
Digestive system338.83M26.91%
Other classes174.44M13.85%
Agent product127.97M10.16%
Respiratory system93.85M7.45%
Other business19.47M1.55%
View all
Industry Currency:CNY
2024/H1
Stock NameRevenueRatio
Pharmaceutical industry1.11B88.29%
Pharmaceutical commerce127.97M10.16%
Other business19.47M1.55%
Region Currency:CNY
2024/H1
Stock NameRevenueRatio
East China region564.94M44.86%
Southwest area133.43M10.60%
Northeast area132.85M10.55%
South China111.81M8.88%
Central China109.83M8.72%
North China99.47M7.90%
Northwest region52.09M4.14%
Other areas35.35M2.81%
Other business19.47M1.55%
View all

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Heat List
CN
Overall
Symbol
Price
% Chg

No Data

Investment Theme Equity Transfer
Equity Transfer
Intraday+0.84%
Traditional Chinese Medicine Concept
Traditional Chinese Medicine Concept
Intraday+0.82%
Pharmaceutical E-commerce
Pharmaceutical E-commerce
Intraday+0.70%